Correction to: Nature Medicine https://doi.org/10.1038/s41591-023-02210-0. Published online 9 February 2023.
In the version of this article originally published, there was a typographical error in the third row, fifth column, of the table in Figure 1, where the population number remaining at 30 months, now reading “7,” appeared originally as “17,” while the Data Availability section has now been updated to note that “The RNAseq dataset is available on dbGAP (https://dbgap.ncbi.nlm.nih.gov/) to researchers with an approved dbGAP profile as outlined on the website, using the accession number phs003199.v1.p1.” The changes are reflected in the HTML and PDF versions of the article.
Rights and permissions
About this article
Cite this article
Soliman, H., Hogue, D., Han, H. et al. Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial. Nat Med (2023). https://doi.org/10.1038/s41591-023-02309-4